Expert perspectives with Peter Pisters, MD

This independent medical education activity features expert interviews focusing on important data from the recent oncology literature in the field of gastrointestinal stromal tumors (GIST).

Lee Lokey, MD, senior medical director for PRIME Oncology, interviews Peter Pisters, MD, on the publication of results of the pivotal Z9001 trial of adjuvant imatinib after resection of localized, primary GIST.

Peter Pisters, MD Associate Clinical Medical Director of the Sarcoma Center and Professor of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States

Disclaimer: The information on this site is intended for healthcare professionals based outside of the United States. You will be asked to provide your credentials before accessing the Webcast and slides. This site may contain information on products outside the approved indications where you practice.

This Webcast is available from 5 May 2009 to 5 May 2010.

This activity is supported by an unrestricted educational grant from Novartis Oncology.